Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity

Proceedings of the Association of American Physicians

Volumn 111, Issue 6, 1999, Pages 611-621

  Oates, J C ^a   Christensen, E F ^a   Reilly, C M ^a   Self, S E ^a   Gilkeson, G S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Lupus nephritis; Nitric oxide; Peroxynitrite; Severity of illness index; Superoxide

Indexed keywords

3 NITROTYROSINE; AZATHIOPRINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; METHOTREXATE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PEROXYNITRITE; PREDNISONE; SUPEROXIDE; THIOL DERIVATIVE;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEGRO; PROTEIN MODIFICATION; RACE DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032728060     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.99110.x     Document Type: Article

References (40)

1. 1 Oates J.C., Ruiz P., Alexander A., et al. Effect of late modulation of nitric oxide production on murine lupus. Clin. Immunol. Immunopathol. 83: 86 92, 1997.
2. 2 Weinberg J.B., Granger D.L., Pisetsky D.S., et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL‐lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG‐monomethyl‐l‐arginine. J. Exp. Med. 179: 651 660, 1994.
3. 3 Belmont H.M., Levartovsky D., Goel A., et al. Increased nitric oxide production accompanied by the up‐regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum. 40: 1810 1816, 1997.
4. 4 Wang J.S., Tseng H.H., Shih D.F., et al. Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis. Nephron 77: 404 411, 1997.
5. 5 Furusu A., Miyazaki M., Abe K., et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int. 53: 1760 1768, 1998.
6. 6 Wanchu A., Khullar M., Deodhar S.D., et al. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol. Int. 18: 41 43, 1998.
7. 7 Rolla G., Brussino L., Bertero M.T., et al. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus. J. Rheumatol. 24: 1066 1071, 1997.
8. 8 Gilkeson G.S., Cannon C., Oates J.C., et al. Correlation of serum measures of nitric oxide production with lupus disease activity. J. Rheumatol. 26: 318 324, 1999.
9. 9 Yang C.W., Yu C.C., Ko Y.C., Huang C.C. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor‐B‐1 (TGF‐B‐1) mRNA expression and diminishes glomerulosclerosis in NZB/W F‐1 mice. Clin. Exp. Immunol. 113: 258 264, 1998.
10. 10 Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120: 227 237, 1994.
11. 11 Ischiropoulos H. & Al‐Mehdi A.B. Peroxynitrite‐mediated oxidative protein modifications. FEBS Lett. 364: 279 282, 1995.
12. 12 St Clair E.W., Wilkinson W.E., Lang T., et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J. Exp. Med. 184: 1173 1178, 1996.
13. 13 Jungersten L., Edlund A., Petersson A.S., Wennmalm A. Plasma nitrate as an index of nitric oxide formation in man: Analyses of kinetics and confounding factors. Clin. Physiol. 16: 369 379, 1996.
14. 14 Tsikas D., Gutzki F.M., Rossa S., et al. Measurement of nitrite and nitrate in biological fluids by gas chromatography‐mass spectrometry and by the Griess assay: Problems with the Griess assay—solutions by gas chromatography‐mass spectrometry. Anal. Biochem. 244: 208 220, 1997.
15. 15 Khan J., Brennan D.M., Bradley N., et al. 3‐Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J. 330: 795 801, 1998.
16. 16 Petruzzelli S., Puntoni R., Mimotti P., et al. Plasma 3‐nitrotyrosine in cigarette smokers. Am. J. Respir. Crit. Care Med. 156: 1902 1907, 1997.
17. 17 Shigenaga M.K., Lee H.H., Blount B.C., et al. Inflammation and NO (X)‐induced nitration: Assay for 3‐nitrotyrosine by HPLC with electrochemical detection. Proc. Natl. Acad. Sci. U.S.A. 94: 3211 3216, 1997.
18. 18 Bombardier C., Gladman D.D., Urowitz M.B., et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35: 630 640, 1992.
19. 19 Isenberg D. Comparison of lupus activity indices. Clin. Exp. Rheumatol. 8: 37 40, 1990.
20. 20 Granger D.L., Taintor R.R., Boockvar K.S., Hibbs Jr. J.B. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol. 268: 142 151, 1996.
21. 21 Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233: 229 240, 1994.
22. 22 Sampson J.B., Rosen H., Beckman J.S. Peroxynitrite‐dependent tyrosine nitration catalyzed by superoxide dismutase, myeloperoxidase, and horseradish peroxidase. Methods Enzymol. 269: 210 218, 1996.
23. 23 Lane D. & Harlow E. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
24. 24 Reveille J.D., Bartolucci A., Alarcon G.S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 33: 37 48, 1990.
25. 25 Austin H.A., Boumpas D.T., Vaughan E.M., Balow J.E. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int. 45: 544 550, 1994.
26. 26 Austin H.A., Boumpas D.T., Vaughan E.M., Balow J.E. High‐risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol. Dial. Transplant. 10: 1620 1628, 1995.
27. 27 Reveille J.D., Moulds J.M., Ahn C., et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 41: 1161 1172, 1998.
28. 28 Petri M. The effect of race on incidence and clinical course in systemic lupus erythematosus: The Hopkins Lupus Cohort. J. Am. Med. Womens Assoc. 53: 9 12, 1998.
29. 29 Alarcon G.S., Roseman J., Bartolucci A.A., et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 41: 1173 1180, 1998.
30. 30 Bakir A.A., Levy P.S., Dunea G. The prognosis of lupus nephritis in African‐Americans: A retrospective analysis. Am. J. Kidney Dis. 24: 159 171, 1994.
31. 31 Bremer V., Tojo A., Kimura K., et al. Role of nitric oxide in rat nephrotoxic nephritis: Comparison between inducible and constitutive nitric oxide synthase. J. Am. Soc. Nephrol. 8: 1712 1721, 1997.
32. 32 Weinberg J.B., Gilkeson G.S., Mason R.P., Chamulitrat W. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL‐lpr/lpr mice. Free Radic. Biol. Med. 24: 191 196, 1998.
33. 33 Privalle C.T., Keng T., Gilkeson G.S., and Weinberg J.B. The role of nitric oxide and peroxynitrite in the pathogenesis of spontaneous murine autoimmune disease. In: The Biology of Nitric Oxide. Stamler J., Gross S.S., and Moncada S. (eds). New York: Elsevier Press, 1996.
34. 34 Brundin L., Svenungsson E., Morcos E., et al. Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus. Ann. Neurol. 44: 704 706, 1998.
35. 35 Gonzalezcrespo M.R., Navarro J.A., Arenas J., et al. Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus. Br. J. Rheumatol. 37: 972 977, 1998.
36. 36 Whittle B.J. Nitric oxide in physiology and pathology. Histochem. J. 27: 727 737, 1995.
37. 37 Zou M., Martin C., Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol. Chem. 378: 707 713, 1997.
38. 38 Wever R.M., Luscher T.F., Cosentino F., Rabelink T.J. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97: 108 112, 1998.
39. 39 Ischiropoulos H., Zhu L., Chen J., et al. Peroxynitrite‐mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298: 431 437, 1992.
40. 40 Fukuyama N., Takebayashi Y., Hida M., et al. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic. Biol. Med. 22: 771 774, 1997.